Furthermore, it was assessed (24) that strong P53 expression in bone marrow progenitor cells was significantly associated with higher AML risk (P = 0.0006) and shorter survival (P = 0.00175) rendering P53 as the stronger predictor of transformation to AML (25). This evidence concerns the gene TP53 and acute myeloid leukemia.